Gainers and Losers: Top Stock Movers on December 2 with Insights
Sandip Raj Gupta
02/Dec/2024

What's Covered
- Pharma, realty, and auto stocks fueled a market rally despite weak GDP data.
- Top gainers included Dixon Technologies, Biocon, and Emami Realty; Cipla and SML Isuzu led the losers.
- Broader market indices surged to a one-month high, showing resilience amid economic concerns.
Market Overview
- Sensex rose 0.6% (458 points) to close at 80,260.
- Nifty 50 climbed 143 points to end at 24,274.
- Gains were driven by pharma, realty, and auto sectors, overcoming weaker GDP growth data.
Top Gainers
1. Dixon Technologies (India)
- Shares surged after its subsidiary, Padget Electronics, announced mass production of Google Pixel smartphones in collaboration with Compal Smart Device India.
2. Biocon
- Stock gained as Biocon Biologics received US FDA approval for Yesintek, a biosimilar to Stelara, targeting Crohn's disease, psoriasis, and more.
3. Emami Realty
- Shares hit the upper circuit following the launch of Emami Aamod, a premium residential project in New Alipore, with an estimated revenue potential of ₹850 crore.
4. Cement Stocks
- Led by Ultratech Cement, which rose nearly 4%, optimism around a sectoral recovery lifted other players like Shree Cement, JK Lakshmi Cement, and ACC by 2-3%.
5. Atul Auto
- Stock advanced following robust November sales, with domestic volumes up 19.4% YoY to 2,535 units.
6. Cochin Shipyard
- Shares surged after the company secured a ₹1,000 crore contract with the Ministry of Defence for naval vessel refitting.
Top Losers
1. Cipla
- Stock declined after 1.4 crore shares (1.7% equity) changed hands in block deals, with promoters reportedly selling at a floor price of ₹1,442.
2. SML Isuzu
- Shares fell after a 16.7% drop in November sales, with total units sold declining to 539 compared to 647 last year.
3. Hyundai Motor India
- Stock slipped as the company reported a 7% decline in November sales, despite achieving strong rural contributions.
4. C.E. Info Systems
- Stock dropped following an announcement to segregate its B2C aspirations from its core B2B operations.
Broader Market Insights
While India's GDP growth slowed to a seven-quarter low in Q2FY25, the markets rallied, driven by sectoral optimism and strong corporate developments. Gains in key stocks showcased resilience, signaling potential growth opportunities despite economic headwinds.
The Upcoming IPOs in this week and coming weeks are Nisus Finance, Emerald Tyre Manufacturers, Rosmerta Digital and Avanse Financial.The Current active IPO is Ganesh Infraworld, Suraksha Diagnostic, Agarwal Toughened.For more details on upcoming IPOs, you can visit our page at Best IPO to Apply Now - IPO List 2024, Latest IPO, Upcoming IPO, Recent IPO News, Live IPO GMP Today - Finance Saathi and stay updated with the latest news on IPO updates on Top News Headlines - Share Market News, Latest IPO News, Business News, Economy News - Finance Saathi.Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst & Finance Saathi Telegram Channel for Regular Share Market, News & IPO Updates.Start your Stock Market Journey and Apply in IPO by opening a Free Demat Account in Choice Broking FinX.
Related News
Disclaimer
The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.
Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.
We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.
By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.